Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots
[Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two ch...
Saved in:
Published in | Journal of pharmaceutical and biomedical analysis Vol. 129; pp. 551 - 557 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier B.V
10.09.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0731-7085 1873-264X 1873-264X |
DOI | 10.1016/j.jpba.2016.08.002 |
Cover
Abstract | [Display omitted]
•A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two chromatographic methods.•DPS is useful to store and ship samples in a cheaper and safer manner.
Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients’ population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC–MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20–25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r2 0.9864 (P<0.0001, 95% CI 0.9699–0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310–0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin. |
---|---|
AbstractList | [Display omitted]
•A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two chromatographic methods.•DPS is useful to store and ship samples in a cheaper and safer manner.
Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients’ population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC–MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20–25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r2 0.9864 (P<0.0001, 95% CI 0.9699–0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310–0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin. Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin. Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin. |
Author | D’Avolio, Antonio Cangemi, Giuliana Tripodi, Gino Favata, Fabio Barco, Sebastiano Castagnola, Elio |
Author_xml | – sequence: 1 givenname: Giuliana surname: Cangemi fullname: Cangemi, Giuliana organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy – sequence: 2 givenname: Sebastiano surname: Barco fullname: Barco, Sebastiano organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy – sequence: 3 givenname: Elio surname: Castagnola fullname: Castagnola, Elio organization: Infectious Disease Unit, Istituto Giannina Gaslini, Genoa, Italy – sequence: 4 givenname: Gino surname: Tripodi fullname: Tripodi, Gino organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy – sequence: 5 givenname: Fabio surname: Favata fullname: Favata, Fabio organization: Department of Medical Sciences, University of Turin, Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Turin, Italy – sequence: 6 givenname: Antonio orcidid: 0000-0002-1321-4126 surname: D’Avolio fullname: D’Avolio, Antonio email: antonio.davolio@unito.it organization: Department of Medical Sciences, University of Turin, Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Turin, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27505127$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1q3DAUhUVJaSZpX6CL4mU3dq5ky9JAN2X6k8KEFtJAd0KWrogG23IkzZTu-g59wz5JPTNJFl0ELtzL5Ttncc4ZORnDiIS8plBRoO3FptpMna7YfFcgKwD2jCyoFHXJ2ubHCVmAqGkpQPJTcpbSBgA4XTYvyCkTfD6ZWJCfH3CHfZgGHHOhR1vsdO-tzj6MRXDFzeW39erv7z9X1xdX18WA-TbYVLgQi3yLxd1Wj9k7bx55E3qfsh-LeaZep0EfTG30aB8eaQo5vSTPne4Tvrrf5-Tm08fvq8ty_fXzl9X7dWmaJculaBsHjkNraymlpQ40CIO87lprGiYF73SnaVtb2vKOd0ip4ctGgAAHTYP1OXl79J1iuNtiymrwyWDf6xHDNikqKa_bJQc2o2_u0W03oFVT9IOOv9RDWDPAjoCJIaWI7hGhoPaNqI3aN6L2jSiQCg6u8j-R8fmQV47a909L3x2lOAe08xhVMh5Hg9ZHNFnZ4J-S_wP8YKdq |
CitedBy_id | crossref_primary_10_3390_biomedicines11071962 crossref_primary_10_3390_antibiotics10040422 crossref_primary_10_1002_dta_2812 crossref_primary_10_1016_j_jchromb_2017_11_040 crossref_primary_10_2147_IDR_S209264 crossref_primary_10_1093_cid_cix757 crossref_primary_10_1093_cid_cix1047 crossref_primary_10_1093_cid_cix1048 crossref_primary_10_1016_j_chroma_2020_461731 crossref_primary_10_3999_jscpt_55_4_185 crossref_primary_10_1016_j_jchromb_2019_121842 crossref_primary_10_1016_j_jpba_2020_113201 crossref_primary_10_1016_j_jpha_2021_11_001 crossref_primary_10_1016_j_seh_2024_100058 crossref_primary_10_1016_j_jpba_2017_07_033 crossref_primary_10_1002_jssc_201901200 crossref_primary_10_3390_molecules27113489 crossref_primary_10_1097_FTD_0000000000000825 crossref_primary_10_1016_j_vascn_2024_107502 crossref_primary_10_3390_antibiotics12030437 crossref_primary_10_3390_biomedicines9101379 crossref_primary_10_1111_jvp_13022 crossref_primary_10_1002_jssc_202400583 crossref_primary_10_1097_FTD_0000000000000600 crossref_primary_10_4155_bio_2017_0269 crossref_primary_10_1016_j_jpba_2018_11_044 crossref_primary_10_36290_far_2022_006 crossref_primary_10_1097_FTD_0000000000000541 crossref_primary_10_1007_s00216_020_02873_5 crossref_primary_10_1016_j_heliyon_2023_e23111 crossref_primary_10_1016_j_jpba_2017_08_002 crossref_primary_10_1002_jssc_202100700 crossref_primary_10_1016_j_talanta_2020_121406 crossref_primary_10_1016_j_jchromb_2022_123131 crossref_primary_10_1016_j_ijantimicag_2021_106281 crossref_primary_10_1080_10826076_2020_1783291 crossref_primary_10_1080_10826076_2023_2262002 crossref_primary_10_1016_j_jpba_2019_03_023 crossref_primary_10_3390_ph17060753 |
Cites_doi | 10.4155/bio.13.345 10.1016/S1473-3099(06)70580-1 10.1016/j.jpba.2010.02.026 10.1016/j.jchromb.2013.08.003 10.1016/S0140-6736(86)90837-8 10.1128/AAC.01367-09 10.1097/QCO.0b013e328332e672 10.1515/cclm-2014-0472 10.1016/S0378-4347(01)00326-7 10.1002/jssc.201000680 10.1592/phco.30.12.1279 10.1016/j.jpba.2013.08.022 10.1016/j.talanta.2013.07.043 10.1097/FTD.0b013e3182a8997c 10.1093/jac/dks285 10.1016/j.jpba.2008.12.016 10.1097/00007691-200010000-00014 10.1093/jac/dki461 10.1248/bpb.b15-00323 |
ContentType | Journal Article |
Copyright | 2016 Elsevier B.V. Copyright © 2016 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier B.V. – notice: Copyright © 2016 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jpba.2016.08.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-264X |
EndPage | 557 |
ExternalDocumentID | 27505127 10_1016_j_jpba_2016_08_002 S0731708516304332 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABFRF ABJNI ABMAC ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADECG ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM M34 M36 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SCH SDF SDG SDP SES SPC SPCBC SSK SSP SSZ T5K TEORI YK3 ~G- 29L 53G AAQXK AATTM AAXKI AAYWO AAYXX ABFNM ABWVN ABXDB ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AJQLL AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMT HMU HVGLF HZ~ R2- SCB SEW SPT SSH WUQ XPP CGR CUY CVF ECM EIF NPM 7X8 ACLOT EFKBS ~HD |
ID | FETCH-LOGICAL-c492t-764f0f506d3888d1f0a07ce53b6dc42875baba163d165b5be11c5947070f044e3 |
IEDL.DBID | AIKHN |
ISSN | 0731-7085 1873-264X |
IngestDate | Sat Sep 27 21:13:44 EDT 2025 Thu Apr 03 07:02:30 EDT 2025 Tue Jul 01 01:17:45 EDT 2025 Thu Apr 24 23:06:06 EDT 2025 Fri Feb 23 02:25:41 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Therapeutic drug monitoring UHPLC–MS/MS Dried plasma spot Colistin Dried blood spots LC–MS |
Language | English |
License | Copyright © 2016 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c492t-764f0f506d3888d1f0a07ce53b6dc42875baba163d165b5be11c5947070f044e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-1321-4126 |
PMID | 27505127 |
PQID | 1815369502 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1815369502 pubmed_primary_27505127 crossref_primary_10_1016_j_jpba_2016_08_002 crossref_citationtrail_10_1016_j_jpba_2016_08_002 elsevier_sciencedirect_doi_10_1016_j_jpba_2016_08_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-09-10 |
PublicationDateYYYYMMDD | 2016-09-10 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of pharmaceutical and biomedical analysis |
PublicationTitleAlternate | J Pharm Biomed Anal |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Tsai, Sun, Chen, Lin, Kuo (bib0090) 2013; 116 Ratjen, Rietschel, Kasel, Schwiertz, Starke, Beier, van Koningsbruggen, Grasemann (bib0065) 2006; 57 Li, Nation, Turnidge, Milne, Coulthard, Rayner, Paterson (bib0005) 2006; 6 Baietto, D’Avolio, Ariaudo, Corcione, Simiele, Cusato, Urbino, Di Perri, Ranieri, De Rosa (bib0045) 2013; 936 Li, Milne, Nation, Turnidge, Coulthard, Johnson (bib0060) 2001; 761 Passing, Bablok (bib0105) 1984; 22 John, Bennett, Blaser (bib0020) 2015 EMEA/CHMP/EWP/192217/2009: Guideline on bioanalytical method validation. The European Medicines Agency, 1 February (2011). Dotsikas, Markopoulou, Koundourellis, Loukas (bib0080) 2011; 34 Baietto, Simiele, D’Avolio (bib0115) 2014; 6 Le Brun, de Graaf, Vinks (bib0055) 2000; 22 Gobin, Lemaître, Marchand, Couet, Olivier (bib0070) 2010; 54 Lim, Ly, Anderson, Yang, Macander, Jarkowski, Forrest, Bulitta, Tsuji (bib0015) 2010; 30 Baietto, D’Avolio, Marra, Simiele, Cusato, Pace, Ariaudo, De Rosa, Di Perri (bib0040) 2012; 67 Yamada, Ishiguro, Oku, Higuchi, Nakagawa, Noguchi, Yasuda, Fukumoto, Iwasaki, Akizawa, Furugen, Yamaguchi, Iseki (bib0025) 2015; 38 Baietto, D’Avolio, Pace, Simiele, Marra, Ariaudo, Di Perri, De Rosa (bib0050) 2014; 88 Baldelli, Cattaneo, Giodini, Baietto, Di Perri, D’Avolio, Clementi (bib0035) 2015; 53 Leporati, Bua, Mariano, Carignano, Stella, Biancone, Vincenti (bib0085) 2014; 36 Jansson, Karvanen, Cars, Plachouras, Friberg (bib0075) 2009; 49 Guidance for industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville, May (2001). Bland, Altman (bib0110) 1986; 1 Nation, Li (bib0010) 2009; 22 D’Avolio, Simiele, Siccardi, Baietto, Sciandra, Bonora, Di Perri (bib0030) 2010; 52 Baietto (10.1016/j.jpba.2016.08.002_bib0040) 2012; 67 10.1016/j.jpba.2016.08.002_bib0095 Li (10.1016/j.jpba.2016.08.002_bib0005) 2006; 6 Passing (10.1016/j.jpba.2016.08.002_bib0105) 1984; 22 Ratjen (10.1016/j.jpba.2016.08.002_bib0065) 2006; 57 Baietto (10.1016/j.jpba.2016.08.002_bib0115) 2014; 6 Dotsikas (10.1016/j.jpba.2016.08.002_bib0080) 2011; 34 Yamada (10.1016/j.jpba.2016.08.002_bib0025) 2015; 38 Leporati (10.1016/j.jpba.2016.08.002_bib0085) 2014; 36 Gobin (10.1016/j.jpba.2016.08.002_bib0070) 2010; 54 10.1016/j.jpba.2016.08.002_bib0100 Baldelli (10.1016/j.jpba.2016.08.002_bib0035) 2015; 53 Tsai (10.1016/j.jpba.2016.08.002_bib0090) 2013; 116 Bland (10.1016/j.jpba.2016.08.002_bib0110) 1986; 1 John (10.1016/j.jpba.2016.08.002_bib0020) 2015 Baietto (10.1016/j.jpba.2016.08.002_bib0050) 2014; 88 Li (10.1016/j.jpba.2016.08.002_bib0060) 2001; 761 Baietto (10.1016/j.jpba.2016.08.002_bib0045) 2013; 936 Lim (10.1016/j.jpba.2016.08.002_bib0015) 2010; 30 D’Avolio (10.1016/j.jpba.2016.08.002_bib0030) 2010; 52 Nation (10.1016/j.jpba.2016.08.002_bib0010) 2009; 22 Le Brun (10.1016/j.jpba.2016.08.002_bib0055) 2000; 22 Jansson (10.1016/j.jpba.2016.08.002_bib0075) 2009; 49 |
References_xml | – volume: 22 start-page: 535 year: 2009 ident: bib0010 article-title: Colistin in the 21st century publication-title: Curr. Opin. Infect. Dis. – volume: 53 start-page: 435 year: 2015 end-page: 444 ident: bib0035 article-title: Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots publication-title: Clin. Chem. Lab. Med. – volume: 54 start-page: 941 year: 2010 end-page: 948 ident: bib0070 article-title: Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography–tandem mass spectrometry publication-title: Antimicrob. Agents Chemother. – start-page: 549 year: 2015 end-page: 555 ident: bib0020 article-title: Polymyxins (polymyxin B and colistin) publication-title: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases – volume: 49 start-page: 760 year: 2009 end-page: 767 ident: bib0075 article-title: Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS publication-title: J. Pharm. Biomed. Anal. – reference: EMEA/CHMP/EWP/192217/2009: Guideline on bioanalytical method validation. The European Medicines Agency, 1 February (2011). – volume: 936 start-page: 42 year: 2013 end-page: 47 ident: bib0045 article-title: Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots publication-title: J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. – volume: 30 start-page: 1279 year: 2010 end-page: 1291 ident: bib0015 article-title: Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing publication-title: Pharmacother. J. Hum. Pharmacol. Drug Ther. – volume: 6 start-page: 425 year: 2014 end-page: 427 ident: bib0115 article-title: How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring? publication-title: Bioanalysis – volume: 38 start-page: 1430 year: 2015 end-page: 1433 ident: bib0025 article-title: Successful colistin treatment of multidrug-resistant Pseudomonas aeruginosa infection using a rapid method for determination of colistin in plasma: usefulness of therapeutic drug monitoring publication-title: Biol. Pharm. Bull. – volume: 761 start-page: 167 year: 2001 end-page: 175 ident: bib0060 article-title: A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography publication-title: J. Chromatogr. B: Biomed. Sci. Appl. – volume: 22 start-page: 431 year: 1984 end-page: 445 ident: bib0105 article-title: Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II publication-title: J. Clin. Chem. Clin. Biochem. – volume: 36 start-page: 182 year: 2014 end-page: 191 ident: bib0085 article-title: Determination by LC–MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration publication-title: Ther. Drug Monit. – volume: 88 start-page: 66 year: 2014 end-page: 70 ident: bib0050 article-title: Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots publication-title: J. Pharm. Biomed. Anal. – volume: 1 start-page: 307 year: 1986 end-page: 310 ident: bib0110 article-title: Statistical methods for assessing agreement between two methods of clinical measurement publication-title: Lancet – volume: 22 start-page: 589 year: 2000 end-page: 593 ident: bib0055 article-title: High-performance liquid chromatographic method for the determination of colistin in serum publication-title: Ther. Drug Monit. – reference: Guidance for industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville, May (2001). – volume: 52 start-page: 774 year: 2010 end-page: 780 ident: bib0030 article-title: HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions publication-title: J. Pharm. Biomed. Anal. – volume: 57 start-page: 306 year: 2006 end-page: 311 ident: bib0065 article-title: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis publication-title: J. Antimicrob. Chemother. – volume: 34 start-page: 37 year: 2011 end-page: 45 ident: bib0080 article-title: Validation of a novel LC–MS/MS method for the quantitation of colistin A and B in human plasma publication-title: J. Sep. Sci. – volume: 6 start-page: 589 year: 2006 end-page: 601 ident: bib0005 article-title: Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections publication-title: Lancet Infect. Dis. – volume: 67 start-page: 2645 year: 2012 end-page: 2649 ident: bib0040 article-title: Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC–MS publication-title: J. Antimicrob. Chemother. – volume: 116 start-page: 593 year: 2013 end-page: 603 ident: bib0090 article-title: Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography–tandem mass spectrometry publication-title: Talanta – volume: 6 start-page: 425 year: 2014 ident: 10.1016/j.jpba.2016.08.002_bib0115 article-title: How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring? publication-title: Bioanalysis doi: 10.4155/bio.13.345 – start-page: 549 year: 2015 ident: 10.1016/j.jpba.2016.08.002_bib0020 article-title: Polymyxins (polymyxin B and colistin) – volume: 6 start-page: 589 year: 2006 ident: 10.1016/j.jpba.2016.08.002_bib0005 article-title: Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(06)70580-1 – volume: 52 start-page: 774 year: 2010 ident: 10.1016/j.jpba.2016.08.002_bib0030 article-title: HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2010.02.026 – volume: 936 start-page: 42 year: 2013 ident: 10.1016/j.jpba.2016.08.002_bib0045 article-title: Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots publication-title: J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2013.08.003 – volume: 1 start-page: 307 year: 1986 ident: 10.1016/j.jpba.2016.08.002_bib0110 article-title: Statistical methods for assessing agreement between two methods of clinical measurement publication-title: Lancet doi: 10.1016/S0140-6736(86)90837-8 – volume: 54 start-page: 941 year: 2010 ident: 10.1016/j.jpba.2016.08.002_bib0070 article-title: Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography–tandem mass spectrometry publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01367-09 – ident: 10.1016/j.jpba.2016.08.002_bib0100 – volume: 22 start-page: 535 year: 2009 ident: 10.1016/j.jpba.2016.08.002_bib0010 article-title: Colistin in the 21st century publication-title: Curr. Opin. Infect. Dis. doi: 10.1097/QCO.0b013e328332e672 – volume: 53 start-page: 435 year: 2015 ident: 10.1016/j.jpba.2016.08.002_bib0035 article-title: Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm-2014-0472 – volume: 761 start-page: 167 year: 2001 ident: 10.1016/j.jpba.2016.08.002_bib0060 article-title: A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography publication-title: J. Chromatogr. B: Biomed. Sci. Appl. doi: 10.1016/S0378-4347(01)00326-7 – volume: 34 start-page: 37 year: 2011 ident: 10.1016/j.jpba.2016.08.002_bib0080 article-title: Validation of a novel LC–MS/MS method for the quantitation of colistin A and B in human plasma publication-title: J. Sep. Sci. doi: 10.1002/jssc.201000680 – volume: 30 start-page: 1279 year: 2010 ident: 10.1016/j.jpba.2016.08.002_bib0015 article-title: Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing publication-title: Pharmacother. J. Hum. Pharmacol. Drug Ther. doi: 10.1592/phco.30.12.1279 – volume: 88 start-page: 66 year: 2014 ident: 10.1016/j.jpba.2016.08.002_bib0050 article-title: Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2013.08.022 – volume: 116 start-page: 593 year: 2013 ident: 10.1016/j.jpba.2016.08.002_bib0090 article-title: Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography–tandem mass spectrometry publication-title: Talanta doi: 10.1016/j.talanta.2013.07.043 – volume: 36 start-page: 182 year: 2014 ident: 10.1016/j.jpba.2016.08.002_bib0085 article-title: Determination by LC–MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration publication-title: Ther. Drug Monit. doi: 10.1097/FTD.0b013e3182a8997c – volume: 67 start-page: 2645 year: 2012 ident: 10.1016/j.jpba.2016.08.002_bib0040 article-title: Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC–MS publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dks285 – volume: 49 start-page: 760 year: 2009 ident: 10.1016/j.jpba.2016.08.002_bib0075 article-title: Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2008.12.016 – volume: 22 start-page: 431 year: 1984 ident: 10.1016/j.jpba.2016.08.002_bib0105 article-title: Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II publication-title: J. Clin. Chem. Clin. Biochem. – volume: 22 start-page: 589 year: 2000 ident: 10.1016/j.jpba.2016.08.002_bib0055 article-title: High-performance liquid chromatographic method for the determination of colistin in serum publication-title: Ther. Drug Monit. doi: 10.1097/00007691-200010000-00014 – volume: 57 start-page: 306 year: 2006 ident: 10.1016/j.jpba.2016.08.002_bib0065 article-title: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dki461 – ident: 10.1016/j.jpba.2016.08.002_bib0095 – volume: 38 start-page: 1430 year: 2015 ident: 10.1016/j.jpba.2016.08.002_bib0025 article-title: Successful colistin treatment of multidrug-resistant Pseudomonas aeruginosa infection using a rapid method for determination of colistin in plasma: usefulness of therapeutic drug monitoring publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b15-00323 |
SSID | ssj0005194 |
Score | 2.350446 |
Snippet | [Display omitted]
•A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify... Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 551 |
SubjectTerms | Anti-Bacterial Agents - blood Anti-Bacterial Agents - chemistry Calibration Chromatography, High Pressure Liquid - methods Colistin Colistin - blood Colistin - chemistry Dried Blood Spot Testing - methods Dried blood spots Dried plasma spot Drug Monitoring - methods Humans LC–MS Limit of Detection Plasma - chemistry Reproducibility of Results Tandem Mass Spectrometry - methods Therapeutic drug monitoring UHPLC–MS/MS |
Title | Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots |
URI | https://dx.doi.org/10.1016/j.jpba.2016.08.002 https://www.ncbi.nlm.nih.gov/pubmed/27505127 https://www.proquest.com/docview/1815369502 |
Volume | 129 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pa9swFBdteumldFvXrtuCBqWX1YkUS3JyLGHB25oQSAO5Cf0zJLROtjiMXsa-w77hPsmeLDtZD-1h4IvNe7LQe376PfzTewhduJjp8jSOIUJFzHVtpI3REWDTHlFUKW5Llu9IpFP2ZcZne6hfn4XxtMoq9oeYXkbr6km7Ws32aj5vT8A5aeIRg4jLKlz76KADu323gQ6uP39NRzumBy37IXr5yCtUZ2cCzWux0r78EBWtwKp8an96Cn-W-9DgGB1VABJfhzm-QHsuf4kux6EC9cMVvt0dqFpf4Us83tWmfniFfvxDEsIqtxgcbR7aKuFlhqfp-Kb_59fv4aQ9nODQXXqNAddiwIn420YFatFWHob1MSLHcK0Ah9-rclAL-betH0DeXKxP0HTw6bafRlXvhciwXqeIEsEyknEibAw5sqUZUSQxjsdaWOPTLK6VVrD0lgquuXaUGt5jCUSQjDDm4teokS9zd4Ywg9huuomxAOWYzTpaM8eUySDzswnE4jeI1isuTVWY3PfHuJM1A20hvZWkt5L0TTMJ6Hzc6qxCWY5npXltSPnIuSTsG8_qfaitLuGr879SVO6Wm7UEXMRj0eNe5jS4w3YevmI-wKjk_D_f-hYd-jtPSqHkHWoU3zfuPSCfQjfRfusnbVb-_RfWFQOk |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NThsxELZoemgvCPoLlNaVKi5lic3aXnJEUVHaJihSEomb5b-VgsomkEQoF8Q78IZ9EmbWu4Ee4FBpT97xruWZHX-j_WaGkG8hFbbMxnFMmUSEI59Y52wC2LTFDDdG-pLle6o6I_HrTJ6tkXadC4O0ysr3R59eeutqpFntZnM6HjcHYJw8Q8Sg0rIK1wvyUmCbAzDqg5tHPA9edkNE6QTFq8yZSPI6n1osPsTVQeRUPnU6PYU-y1PoZIOsV_CRHscVbpK1ULwhe_1Yf3q5T4cP6VSzfbpH-w-VqZdvyfUjihA1hadgZuPYVIlOcjrq9Lvtv7d3vUGzN6Cxt_SMAqqlgBLp5cJEYtFKHh6LHqKgcE0BhV-Y8qEeom9fD0DUPJ-9I6OTH8N2J6k6LyROtA7nSaZEznLJlE8hQvY8Z4ZlLsjUKu8wyJLWWAMb77mSVtrAuZMtkYH_yJkQIX1PGsWkCB8JFeDZ3VHmPAA54fNDa0UQxuUQ9_kMPPEW4fWOa1eVJcfuGH90zT8716gljVrS2DKTwZzvqznTWJTjWWlZK1L_Y1oaTo1n532tta7hm8MfKaYIk8VMAyqSqWpJlPkQzWG1DqyXDyAq2_7Pt34hrzrDXld3f57-3iGv8Q7SUzj7RBrzq0XYBQw0t59LG78H8MoEZg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+validation+of+UHPLC-MS%2FMS+methods+for+the+quantification+of+colistin+in+plasma+and+dried+plasma+spots&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=Cangemi%2C+Giuliana&rft.au=Barco%2C+Sebastiano&rft.au=Castagnola%2C+Elio&rft.au=Tripodi%2C+Gino&rft.date=2016-09-10&rft.issn=1873-264X&rft.eissn=1873-264X&rft.volume=129&rft.spage=551&rft_id=info:doi/10.1016%2Fj.jpba.2016.08.002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon |